New York Life Investment Management’s Arcellx ACLX Stock Holding History

New York Life Investment Management’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,243	Closed	-$3.01M	–	779
2026 Q1	$3.01M	Buy	+26,243	New	+$2.32M	0.03%	447

Other funds holding ACLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's ACLX Position: Q2 2026 in Review

New York Life Investment Management sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 26,243 shares — an estimated $3.01M sold.

New York Life Investment Management first reported a position in ACLX in Q1 2026 and held it in 1 quarter. The position peaked at $3.01M in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

New York Life Investment Management reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
New York Life Investment Management sold 26,243 Arcellx shares in Q2 2026, an estimated $3.01M.
New York Life Investment Management first reported a position in Arcellx in Q1 2026 and held it in 1 quarter.
New York Life Investment Management's Arcellx position peaked at $3.01M in Q1 2026.
2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.